Filing Details
- Accession Number:
- 0001773751-24-000284
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-05 18:37:11
- Reporting Period:
- 2024-09-03
- Accepted Time:
- 2024-09-05 18:37:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1773751 | Hims & Hers Health Inc. | HIMS | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1837815 | Melissa Baird | 2269 Chestnut Street, #523 San Francisco CA 94123 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2024-09-03 | 11,884 | $0.40 | 597,684 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-09-03 | 6,849 | $14.49 | 590,835 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2024-09-03 | 5,035 | $14.49 | 585,800 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2024-09-04 | 11,749 | $0.40 | 597,549 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-09-04 | 5,035 | $14.65 | 592,514 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2024-09-04 | 6,714 | $14.65 | 585,800 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2024-09-05 | 11,749 | $0.40 | 597,549 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-09-05 | 5,035 | $14.40 | 592,514 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2024-09-05 | 6,714 | $14.40 | 585,800 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-09-03 | 11,884 | $0.00 | 11,884 | $0.40 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-09-04 | 11,749 | $0.00 | 11,749 | $0.40 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-09-05 | 11,749 | $0.00 | 11,749 | $0.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 484,176 | 2028-03-28 | No | 4 | M | Direct | |
| 472,427 | 2028-03-28 | No | 4 | M | Direct | |
| 460,678 | 2028-03-28 | No | 4 | M | Direct |
Footnotes
- The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.33 - $14.70. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.335 - $14.665. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.465 - $14.79. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.475 - $14.785. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.20 - $14.63. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.17 - $14.645. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.
Billionaire Hedge Funds
